HCA Healthcare, Inc. reported a significant increase in financial performance for the second quarter of 2025, with revenues rising to $18.605 billion, up 6.4% from $17.492 billion in the same quarter of 2024. Net income attributable to the company reached $1.653 billion, or $6.83 per diluted share, compared to $1.461 billion, or $5.53 per diluted share, in the prior year. The increase in revenue was primarily driven by a 3.9% rise in revenue per equivalent admission and a 2.3% increase in equivalent admissions. The company also noted a 2.1% increase in consolidated admissions and a 1.0% rise in emergency department visits during the quarter.
For the first six months of 2025, HCA Healthcare's revenues totaled $36.926 billion, reflecting a 6.0% increase from $34.831 billion in the same period of 2024. Net income for the six-month period was $3.263 billion, or $13.28 per diluted share, compared to $3.052 billion, or $11.47 per diluted share, in the previous year. The company attributed the revenue growth to a 3.2% increase in revenue per equivalent admission and a 2.7% rise in equivalent admissions. The same facility revenues also increased by 5.9% for the first half of 2025.
Operationally, HCA Healthcare continued to expand its footprint, operating 191 hospitals and 124 freestanding outpatient surgical centers as of June 30, 2025. The company made strategic acquisitions, spending $326 million on two hospital facilities and non-hospital healthcare entities during the first half of 2025, compared to $131 million in the same period of 2024. The company also reported a decline in cash and cash equivalents to $939 million from $1.933 billion at the end of 2024, primarily due to increased short-term borrowings and long-term debt.
The company’s expenses also saw notable changes, with salaries and benefits as a percentage of revenues decreasing slightly from 43.9% in Q2 2024 to 43.7% in Q2 2025. However, supply costs per equivalent admission increased by 5.5%, driven by higher costs for medical devices. Interest expenses rose to $568 million in Q2 2025 from $506 million in Q2 2024, reflecting an increase in the average debt balance, which was $44.506 billion for the quarter.
Looking ahead, HCA Healthcare is navigating potential challenges posed by the One Big Beautiful Bill Act (OBBBA), which may impact Medicaid eligibility and federal healthcare spending. The company is actively monitoring these developments and implementing resiliency plans to enhance efficiency and reduce costs. Despite these uncertainties, HCA Healthcare remains focused on leveraging its operational strengths and strategic initiatives to sustain growth and profitability in the evolving healthcare landscape.
About HCA Healthcare, Inc.
HCA Healthcare, Inc. is a leading U.S. health care services company operating hospitals, outpatient centers, and behavioral facilities. It provides comprehensive medical, surgical, mental health, and outpatient services across multiple states and England. The company focuses on delivering high-quality, cost-effective care, leveraging extensive networks, operational excellence, and strategic growth in inpatient, outpatient, and specialty care markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.